Skip to content

PharmaTopo™

  • Home
  • About PharmaTopo.com
  • Disclaimer for PharmaTopo™
× Close Menu
Open Menu

Tag: Pharmacy

January 31, 2024

Vaccine Hesitancy

Covid-19, Medical, Parenteral Drugs, Pharmacy, Vaccine

Stuart R. Gallant, MD, PhD In Danielle Ofri’s recent column in The New York Times “My Patients Used to Be Enthusiastic About the Covid Vaccine. …

Stuart Gallant
January 4, 2024

Plant-Based Drug Discovery—Nature’s Pharmacy

Analytical, Antibiotics, CMC, Patent, Pharmaceutical Development, Pharmacy, Pre-Clinical

Stuart R. Gallant, MD, PhD Before there was a pharmaceutical industry, humans looked to plants as source of medicines.  Today’s post focuses on medicines derived…

Stuart Gallant
October 26, 2023

Wound Care and Healing

Antibiotics, Clinical, Medical, Pharmacy

Stuart R. Gallant, MD, PhD CAVEAT:  THIS POST INCLUDES PHOTOGRAPHS OF TISSUE INJURIES AND MAY CAUSE SOME READERS DISCOMFORT. An 81-year-old, retired accountant is on…

Stuart Gallant
October 17, 2023

Nicotine and Vapes

Marketed Products, Medical, Pharmacy

Stuart R. Gallant, MD, PhD Humans have been smoking tobacco for more than 10,000 years, but e-cigarettes (“vapes”) have only existed for less than two…

Stuart Gallant
September 11, 2023

Trends in Pharmaceutical Autoinjector Design and Use

Clinical, CMC, Parenteral Drugs, Patent, Pharma Economics, Pharmaceutical Development, Pharmaceutical Manufacturing, Pharmacy, Planning, Pre-Clinical

Stuart R. Gallant, MD, PhD In today’s post, some important aspects of development and manufacture of combination products with pharmaceutical autoinjectors are considered.  Pharmaceutical autoinjectors…

Stuart Gallant
September 1, 2023

Subcutaneous Suspensions for Challenging Formulations

CMC, Parenteral Drugs, Pharmaceutical Development, Pharmaceutical Manufacturing, Pharmacy

Stuart R. Gallant, MD, PhD In today’s post, we will look at subcutaneous suspensions as a way of meeting difficult drug delivery challenges.  To decide…

Stuart Gallant
June 19, 2023

Leased Lab Space

Finance, Logistics, Pharma Economics, Pharmaceutical Development, Planning

Stuart R. Gallant, MD, PhD In the last two decades, startup pharmaceutical companies have become increasingly frugal with investment capital.  One of the ways to…

Stuart Gallant
March 26, 2023

Investing in Pharmaceutical Startups

Finance, Patent, Pharmaceutical Development, Pharmacy, Planning, Pre-Clinical

Stuart R. Gallant, MD, PhD PharmaTopo recently posted on the topic of founding a pharmaceutical startup.  Today’s post looks at pharmaceutical startups from the investor’s…

Stuart Gallant
March 11, 2023

Founding a Pharma Startup

Finance, Patent, Pharmaceutical Development, Pharmacy, Planning, Pre-Clinical

Stuart R. Gallant, MD, PhD In the late 1950s, electronics scientists and engineers like Robert Noyce, Gordon Moore, and Eugene Kleiner invented the idea that…

Stuart Gallant
March 2, 2023

Steroid Hormone Replacement Therapy (Part 2 of 2)

Endocrine, Medical, Pharmacy

Stuart R. Gallant, MD, PhD Steroid hormone replacement therapy (HRT) is a topic that has been in the scientific and popular press a lot recently. …

Stuart Gallant
March 2, 2023

Male (Androgen) and Female (Estrogen) Hormone Pharmacology (Part 1 of 2)

Endocrine, Medical, Pharmacy

Stuart R. Gallant, MD, PhD Steroid hormones are frequently in the news—sometimes in infamy, as in the case of sports doping, but also in many…

Stuart Gallant
January 25, 2023

Skin pH, Water Content, and Water Loss

Clinical, Dermatology, Medical, Pharmacy

Stuart R. Gallant, MD, PhD Our skin does so much for us. Skin protects us against infection and dehydration.  Skin allows us to be in…

Stuart Gallant
January 18, 2023

Solving Drug Shortages

CMC, Finance, Marketed Products, Pharma Economics, Pharmaceutical Manufacturing, Pharmacy, Planning, Portfolio Management, Risk Management

Stuart R. Gallant, MD, PhD Imagine that you have an infection, and you need a common antibiotic, but you cannot find a drugstore that is…

Stuart Gallant
November 23, 2022

Oral Delivery of Protein Drugs

Clinical, CMC, Medical, Pharmaceutical Development, Pharmaceutical Manufacturing, Pharmacy, Pre-Clinical, Uncategorized

Stuart R. Gallant, MD, PhD Proteins and peptides are commonly delivered subcutaneously and by infusion; however, these approaches have disadvantages.  Among the chief problems are:…

Stuart Gallant
November 14, 2022

Immediate, Delayed, and Extended-Release Drug Products

Analytical, Clinical, CMC, Pharmaceutical Development, Pharmaceutical Manufacturing, Pharmacy, Uncategorized

Stuart R. Gallant, MD, PhD The focus of today’s post is oral drug release—immediate, delayed, and extended.  Many technologies exist for controlling drug release—the focus…

Stuart Gallant
October 20, 2022

Vaccines for Lyme Disease

Clinical, Marketed Products, Parenteral Drugs, Pharma Economics, Pharmaceutical Development, Pharmacy, Vaccine

Stuart R. Gallant, MD, PhD In 1991, Helmut and Erika Simon, two German tourists hiking in the Alps near the Austrian/Italian border when they saw…

Stuart Gallant
September 24, 2022

Anti-TNF Medications

Clinical, Finance, Marketed Products, Medical, Parenteral Drugs, Patent, Pharma Economics, Pharmaceutical Development, Pharmacy

Stuart R. Gallant, MD, PhD I have a weakness for old Hollywood movies.  The movie still that appears above this paragraph depicts John Carradine in…

Stuart Gallant
September 20, 2022

Pharmaceutical Patent Strategy

Clinical, CMC, Marketed Products, Patent, Pharmaceutical Development, Pharmacy, Planning, Portfolio Management, Risk Management

Stuart R. Gallant, MD, PhD When I think of patent law, I am reminded of a line from the play A Man for All Seasons. …

Stuart Gallant
September 16, 2022

Moderna’s Bivalent Booster

Clinical, Marketed Products, Medical, Parenteral Drugs, Pharmaceutical Development, Pharmacy

Stuart R. Gallant, MD, PhD Back in April, PharmaTopo posted on lipid nanoparticle formulations for Covid-19 vaccines [1].  Because the Moderna bivalent vaccine recently arrived…

Stuart Gallant
August 25, 2022

Pharmaceutical Design Focus:  Clot Busters (2 of 2)

Clinical, CMC, Finance, Marketed Products, Medical, Parenteral Drugs, Patent, Pharma Economics, Pharmaceutical Development, Pharmaceutical Manufacturing, Pharmacy, Portfolio Management, Raw Materials

Stuart R. Gallant, MD, PhD In the first part of this post, we looked at urokinase.  In the second part, we will look at tissue…

Stuart Gallant
August 25, 2022

Pharmaceutical Design Focus:  Clot Busters (1 of 2)

Clinical, CMC, Finance, Marketed Products, Medical, Parenteral Drugs, Patent, Pharma Economics, Pharmaceutical Development, Pharmaceutical Manufacturing, Pharmacy, Portfolio Management, Raw Materials

Stuart R. Gallant, MD, PhD This November will be the 35th anniversary of the approval of tissue plasminogen activator (tPA, alteplase) a leading treatment for…

Stuart Gallant
July 1, 2022

Improving the Patient-Doctor Conversation

Medical, Pharmacy

Stuart R. Gallant, MD, PhD Eventually, all of us need to talk to a doctor or a nurse, maybe about a headache, flu symptoms, or…

Stuart Gallant
April 3, 2022

Lipid Nanoparticles for Covid-19 Vaccines

CMC, Covid-19, Marketed Products, Parenteral Drugs, Patent, Pharmaceutical Manufacturing, Pharmacy, Raw Materials

Stuart R. Gallant, MD, PhD Hopefully, you have received your Covid-19 vaccine.  If you did, there’s a pretty good chance it was delivered in lipid…

Stuart Gallant
March 27, 2022

Payment for Pharmaceuticals

Insurance, Marketed Products, Pharma Economics, Pharmacy

Stuart R. Gallant, MD, PhD The United States has a mixed public and private insurance system for health care.  Payments for pharmaceuticals are provided through…

Stuart Gallant

Search

Archives

  • March 2025
  • February 2025
  • January 2024
  • October 2023
  • September 2023
  • August 2023
  • June 2023
  • April 2023
  • March 2023
  • January 2023
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021

Recent Posts

  • Preparation of an Investigational New Drug (IND) Application
  • The 4 Axes of Drug Development Readiness
  • Vaccine Hesitancy
  • Plant-Based Drug Discovery—Nature’s Pharmacy
  • Wound Care and Healing

Recent Comments

    Archives

    • March 2025
    • February 2025
    • January 2024
    • October 2023
    • September 2023
    • August 2023
    • June 2023
    • April 2023
    • March 2023
    • January 2023
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021

    Categories

    • Analytical
    • Antibiotics
    • Clinical
    • CMC
    • Covid-19
    • Dermatology
    • Endocrine
    • Finance
    • Insurance
    • Knowledge
    • Logistics
    • Marketed Products
    • Medical
    • Oral Drugs
    • Parenteral Drugs
    • Patent
    • Pharma Economics
    • Pharmaceutical Development
    • Pharmaceutical Manufacturing
    • Pharmacy
    • Planning
    • Portfolio Management
    • Pre-Clinical
    • Raw Materials
    • Risk Management
    • Royalty
    • Uncategorized
    • Vaccine

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    © 2025 PharmaTopo™
     / Theme: Really Simple / License: GPLv3